LAMOTHE; Marie

Patent Applications and Registrations

Patent applications and USPTO patent grants for LAMOTHE; Marie.The latest application filed is for "antibody-drug-conjugate and its use for the treatment of cancer".

Company Profile

1.11.17

LAMOTHE; Marie - Montredon Labessonnie FR
Lamothe; Marie - Castres FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody-drug-conjugate And Its Use For The Treatment Of Cancer App 20220105195 - RILATT; Ian ; et al.	2022-04-07
Antibody-drug-conjugate and its use for the treatment of cancer Grant 11,219,693 - Rilatt , et al. January 11, 2	2022-01-11
Derivatives Of Dolastatin 10 And Auristatins App 20210107868 - PEREZ; Michel ; et al.	2021-04-15
Antibody-drug-conjugate And Its Use For The Treatment Of Cancer App 20210038738 - RILATT; Ian ; et al.	2021-02-11
Antibody-drug-conjugate and its use for the treatment of cancer Grant 10,912,841 - Rilatt , et al. February 9, 2	2021-02-09
Composition for the treatment of IGF-1R expressing cancer Grant 10,858,423 - Jouhanneaud , et al. December 8, 2	2020-12-08
Igf-1r Antibody-drug-conjugate And Its Use For The Treatment Of Cancer App 20200270352 - RILATT; Ian ; et al.	2020-08-27
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer Grant 10,633,448 - Rilatt , et al.	2020-04-28
Derivatives Of Dolastatin 10 And Auristatins App 20200010414 - PEREZ; Michel ; et al.	2020-01-09
Antibody-drug-conjugate And Its Use For The Treatment Of Cancer App 20190269788 - RILATT; Ian ; et al.	2019-09-05
Antibody-drug-conjugate and its use for the treatment of cancer Grant 10,314,921 - Rilatt , et al.	2019-06-11
Derivatives Of Dolastatin 10 And Auristatins App 20180222858 - PEREZ; Michel ; et al.	2018-08-09
Use Of (4-hydroxy-2-methyl-1,1-dioxido-2h-benzo[e][1,2]thiazine-3-yl)(naph- Thalene-2-yl) Methanone In The Prevention And/or Treatment Of Non-alcoholic Steatohepatitis App 20180140609 - LAMOTHE; Marie ; et al.	2018-05-24
Derivatives Of Dolastatin 10 And Auristatins App 20160083420 - PEREZ; Michel ; et al.	2016-03-24
Derivatives Of Dolastatin 10 And Auristatins App 20160068567 - PEREZ; Michel ; et al.	2016-03-10
Derivatives Of Dolastatin 10 And Auristatins App 20160068566 - PEREZ; Michel ; et al.	2016-03-10
Derivatives of benzothiazines, preparation thereof and application thereof as drugs Grant 9,187,438 - Perez , et al. November 17, 2	2015-11-17
Cinnamoyl-piperazine derivatives and their use as par-1 antagonists Grant 8,513,258 - Perez , et al. August 20, 2	2013-08-20
Cinnamoyl-piperazine Derivatives And Their Use As Par-1 Antagonists App 20120232097 - PEREZ; Michel ; et al.	2012-09-13
Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists Grant 8,217,046 - Perez , et al. July 10, 2	2012-07-10
Derivatives Of Benzothiazines, Preparation Thereof And Application Thereof As Drugs App 20110319326 - Perez; Michel ; et al.	2011-12-29
Phenylpentadienoyl derivatives and their use as PAR 1 antagonists Grant 8,022,064 - Perez , et al. September 20, 2	2011-09-20
Phenylpentadienoyl Derivatives And Their Use As Par 1 Antagonists App 20100003260 - Perez; Michel ; et al.	2010-01-07
Cinnamoyl-piperazine Derivatives And Their Use As Par-1 Antagonists App 20090176803 - Perez; Michel ; et al.	2009-07-09
Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins App 20040204417 - Perez, Michel ; et al.	2004-10-14
Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same App 20040092524 - Perez, Michel ; et al.	2004-05-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.